Featured Posts
Blog
This week in health care policy: October 8–15, 2026
Innovation watch Merck expects faster production of its personalized cancer vaccine. CEO Rob Davis told CNBC the six-week turnaround for…
Blog
This week in health care policy: October 5–9, 2026
Drug pricing and 340B PhRMA sues to block GLOBE. On October 7, PhRMA sued to block the most-favored-nation drug-pricing model…
Blog
This week in health care policy: September 28 – October 2, 2026
Drug pricing CMS finalizes GLOBE pilot. On September 30, CMS finalized the Global Benchmark for Efficient Drug Pricing model, a…
Search Posts
Citation
FDA Drug approval delays; new drug called Provenge
Newsletter
Healthy Eating, Big Labor Fights Itself and the War on Mining
A new Food and Drug Administration study sparks debate over the health benefits of eating fish. Factions of the labor union known as UNITE-HERE fight…
Study
The Case for Compensating Live Organ Donors
Full Document Available in PDF Conflicting opinions on the ethics of organ…
Newsletter
Celebrating Earth Day, the FDA Drags Its Feet and Health Scares Debunked
CEI releases a new video titled “Humans Make Earth Day Better.” Promising anti-cancer drug Provenge languishes in the federal approval process despite mounting evidence of…
Comment
CEI Comments on Draft FDA Risk-Benefit Assessment of Fish Consumption
CEI applauds the FDA's even-handed approach.
News Release
Good News, But Prostate Cancer Patients Still Waiting
Sunday’s meeting of the American Association of Cancer Research saw new hope for prostate cancer patients, as researchers announced very favorable results for the drug…